|
|
|
| Webinar: Insights and Strategies for GMP Manufacturing of RNA-Lipid Nanoparticles | The emergence of RNA-encapsulated-lipid nanoparticles (LNPs) has introduced a seismic shift in biopharma innovation. But how will the industry adapt to diversifying applications and scales going forward? Join David Sokolowski with Cytiva and Jason Coleman with Precision NanoSystems to learn how to leverage manufacturing workflows, processes, and technologies for mRNA vaccine and therapeutic development. |
|
|
|
|
By Advancing RNA Live | In response to an audience poll question gauging which cGMP materials have proven the most difficult to source, our speakers provide additional clarity around which IVT & LNP-related materials today are more “commoditized”. |
|
|
|
By Antony Hitchcock, AGH Bioconsulting | Today’s standards for plasmid DNA production lack specificity, and manufacturers have been clamoring for more. In late 2023, USP published draft General Chapter <1040> to help fill in the cracks. |
|
|
|
By Ray Knox, KBDG | We encounter the term “the end in mind” in product development frequently, but many are unsure what it really means and when it matters. This article sheds light. |
|
|
|
|
|
|
|
| Defining A Process For Your Unique mRNA | Infographic | Sartorius | Define a process for your unique mRNA with this interactive guide to pDNA, mRNA, and LNP. Overcome challenges with solutions that can help you develop a next-generation production strategy. |
|
|
| Compatible Platforms For Microbial Identification | Application Note | Thermo Fisher Scientific | Reduce the time-to-results for microbial identification by taking advantage of the shorter run cycle and off-instrument data analysis provided by this optimized and validated workflow. |
|
|
.png){kind=logo}
